In the early stage of IPF, a series of inflammatory cells such as macrophages will move to the injury site, and T cells will be activated to secrete inflammatory factors, leading to lung inflammation, and the loss of TET2 will affect the inflammatory response (Tsiouplis et al., 2020). Here, TET2 is linked to idiopathic pulmonary fibrosis.